Relievant Medsystems said it named former Cameron Medical chief Kevin Hykes to be its new CEO, effective immediately.
Relievant makes the Intracept device for treating lower back pain. Hykes was most recently chairman & CEO of Metavention, which is developing treatments for Type II diabetes, and an operating partner at Versant Ventures.
“Kevin is a highly respected industry veteran with an exceptional track record of building and leading strong teams, rapidly growing businesses, and developing markets for groundbreaking, PMA-class devices. Kevin’s experience and track record commercializing medical technologies around the world will be a significant asset as he leads Relievant into the next phase of its growth,” Relievant chairman Richard Mott said in prepared remarks. “On behalf of the entire board of directors, we thank Alex for his contributions which have created a solid foundation for the company’s future success. We look forward to his continued leadership as our chief operating officer.”
“I am thrilled to join Relievant and am impressed by what the company has accomplished to date. The results of the Smart trial, the medical device industry’s first successful Level 1, randomized sham-controlled trial for chronic low back pain, demonstrate the significant potential for the Intracept procedure to fill a critical gap in the treatment continuum for chronic low back pain, and to provide physicians and patients with a much-needed new solution,” Hykes added. “I look forward to working with the Relievant team to deliver on our mission to improve the quality of lives for millions of patients suffering from this disabling condition.”
Breathtec CEO La Torre resigns
Breathtec Biomedical (OTC:BTHCF) said CEO Guy La Torre resigned “to pursue other ventures” and that it plans to name an interim chief executive “in due course.”
RTI Surgical taps director Singer for top admin, finance spots
RTI Surgical (NSDQ:RTIX) said it named one of its directors, Jonathon Singer, as chief financial & administrative officer, effective Oct. 2. RTI said Singer stepped down from the board effective Sept. 18.
- Integer accounting chief Mazza to retire
- Histogenics CMO Matthews to step down
- Lombard Medical appoints Hornsby as sales & marketing VP
- HistoSonics names R&D VP and science chief
- Pulmodyne hires Greenfield as medical director
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.